Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis
- 1 August 2012
- journal article
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 27 (6) , 463-469
Abstract
Previous studies on the impact of cannabis use disorders (CU) on outcome in psychosis were predominantly based on non representative samples, often have not controlled for confounders and rarely focused on adolescent patients. Thus, the aims of the present study were to assess: (i) prevalence of CU; (ii) baseline and pretreatment differences between CU and those without CU (NCU); (iii) the impact of baseline and course of CU on 18-month outcomes in a representative cohort of adolescents with early onset first episode psychosis (EOP). The sample comprised 99 adolescents (age 14 to 18) with EOP (onset age 14 to 17), admitted to the Early Psychosis Prevention and Intervention Centre in Australia. Data were collected from medical files using a standardized questionnaire. Prevalence of lifetime CU was 65.7%, of current CU at baseline 53.5%, and of persistent CU throughout treatment 26.3%. Baseline CU compared to NCU had significantly higher illness-severity, lower psychosocial functioning, less insight, lower premorbid functioning and longer duration of untreated psychosis. Compared to all other groups, only persistent CU was linked to worse outcomes and more service disengagement. Effect sizes were medium controlling for relevant confounders. Medication non-adherence did not explain the association between persistent CU and worse outcome. Baseline CU was associated with worse baseline characteristics, but only persistent CU was linked with worse outcome. About half of those with baseline CU reduced cannabis during treatment. For these, effectively treating the psychotic disorder may already be beneficial. However, future research is necessary on the reasons for persistent CU in EOP and its treatment.Keywords
This publication has 31 references indexed in Scilit:
- Treatment of Cannabis Use Among People With Psychotic or Depressive DisordersThe Journal of Clinical Psychiatry, 2010
- Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosisSchizophrenia Research, 2009
- Cannabis use in children and adolescents with first episode psychosis: Influence on psychopathology and short-term outcome (CAFEPS study)Schizophrenia Research, 2009
- Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysisSchizophrenia Bulletin, 2009
- The First‐Episode Psychosis Outcome Study: premorbid and baseline characteristics of an epidemiological cohort of 661 first‐episode psychosis patientsEarly Intervention in Psychiatry, 2007
- Comorbid substance use and age at onset of schizophreniaThe British Journal of Psychiatry, 2006
- Cannabis use and outcome of recent onset psychosisEuropean Psychiatry, 2005
- The impact of substance use disorders on clinical outcome in 643 patients with first‐episode psychosisActa Psychiatrica Scandinavica, 2005
- Methodological pitfalls in early detection studies – the NAPE Lecture 2002Acta Psychiatrica Scandinavica, 2003
- Cannabis and First‐Episode Psychosis: The CAP Project2002